Learn about KOMBIGLYZE® XR (saxagliptin and metformin HCl extended-release), a treatment for type 2 diabetes in adults. Visit KombiglyzeXR-HCP.com for more information.
Learn about KOMBIGLYZE® XR (saxagliptin and metformin HCl extended-release), a treatment for type 2 diabetes in adults. Visit KombiglyzeXR-HCP.com for more information.
Learn about KOMBIGLYZE® XR (saxagliptin and metformin HCl extended-release), a treatment for type 2 diabetes in adults. Visit KombiglyzeXR-HCP.com for more information.
Learn about KOMBIGLYZE® XR (saxagliptin and metformin HCl extended-release), a treatment for type 2 diabetes in adults. Visit KombiglyzeXR-HCP.com for more information.
Learn about KOMBIGLYZE® XR (saxagliptin and metformin HCl extended-release), a treatment for type 2 diabetes in adults. Visit KombiglyzeXR-HCP.com for more information.
If you are an adult patient with type 2 diabetes and need help managing your blood sugar, JENTADUETO may be an option for you. JENTADUETO is a prescription medicine that contains linagliptin and metformin. Please read the full Prescribing Information for
If you are an adult patient with type 2 diabetes and need help managing your blood sugar, JENTADUETO may be an option for you. JENTADUETO is a prescription medicine that contains linagliptin and metformin. Please read the full Prescribing Information for
Riomet™ (metformin HCl oral solution) is the first and only liquid metformin to treat Type 2 diabetes. Riomet® is easy to use, easy to measure and easy to swallow.
Riomet™ (metformin HCl oral solution) is the first and only liquid metformin to treat Type 2 diabetes. Riomet® is easy to use, easy to measure and easy to swallow.
TKL Research in Paramus is recruiting participants aged 10 and up who have Type II Diabetes and currently take Metformin to attend a clinical trial to evaluate different flavors of the oral solution Riomet (also known as Metformin).
XIGDUO XR (dapagliflozin and metformin HCl extended-release) tablets for adult type 2 diabetes treatment in addition to diet and exercise that uses a combination therapy of SGLT2i + metformin.